Homecare, Personal Care and Hygiene

Huge consumer appetite and expectation in the fast-moving home care, personal care and hygiene markets represents both opportunity and challenge when it comes to IP. From refining an existing formulation, to launching an entirely new proposition built on new technology, we appreciate the commercial and regulatory context and the critical role of patents alongside design and brand protection.

Our chemistry team has expertise in patenting novel formulations, additives and actives, even in crowded IP space. We have a deep understanding of how to deploy, and advocate successfully for, functional and parametric characteristics which can distinguish a new product from structurally similar products. Similarly, we are familiar with the quantitative and qualitative tests that are a part and parcel of innovation in this space, and we proactively contribute to experiment design – including panel assessments where appropriate - so as to arrive at a data set that supports the patent claims that we collaboratively work towards.

We recognise the value of even modest-seeming improvements in a product and we appreciate how such developments can support and strengthen brand loyalty.

Sustainability is a significant imperative that drives innovation in this space and which can present unique challenges in obtaining strong IP. Green innovation aligns with our values and we are adept at identifying those aspects of a sustainable product that are amenable to patent protection. We fully appreciate that the sustainability journey encompasses multiple strands of innovation, including improving the green credentials of existing product lines whilst in parallel investing in entirely new technologies for future platforms.

Naturally, there are challenges for any innovator in operating in such an active IP space and we work hand-in-hand with clients to understand the relevant patent landscape in a way that contributes meaningfully to product design and development, refining down and communicating clearly on specific risks and options for mitigation. On which note, we have an enviable track record in EPO opposition proceedings, curtailing or completely knocking out competitors’ patents. On the flip side, we are tenacious and successful defenders of hard-won patents and our team encompasses opposition specialists with decades of experience and success.

Innovation in packaging, containers and dispensing systems often goes alongside innovation in the chemistry space and we are creative in seeking to identify any synergy or cooperative effects between the formulated product and the functionality of the packaging.

As the forward-looking IP firm, we are excited to be working with companies committed to delivering innovation in this exciting and evolving field.

Meet our Specialists

OUR PEOPLE
Open pages of Green IP Report

Green IP Report

Patents are both a driver and a barometer of innovation

Our report examines the role of patents in making innovative ‘green’ technologies into a reality as well as how the patent landscape can be used to identify opportunities for partnering, collaboration and investment.

We share our enthusiasm and admiration for commercially-focused innovation across a diverse range of technologies, from repurposing carbon dioxide to make protein-rich foods, to the multi-faceted approach to a circular plastics economy. We also discuss the tantalising prospect of AI-mediated renewable energy supply, and the harnessing of battery tech from the EV boom to drive energy efficiency in consumer devices. This report reflects our passion for technology solutions that tackle our shared global challenge.

Download the Report

Read our Blogs

Careful with that saisie application

Careful with that saisie application

by Matthew Naylor

2025 Week 52 They can be conveniently bundled together informally as “provisional measures” at the UPC. But orders for preserving evidence (saisie orders) and preliminary injunctions are different in ...

When success does not mean survival – Generics knock out Sanofi’s cancer drug patent at the UPC

When success does not mean survival – Generics knock out Sanofi’s cancer drug patent at the UPC

by Julie Carlisle

2025 Week 51 Generic pharmaceutical companies scored their first big win at the UPC last week, with the Munich Local Division (LD) revoking Sanofi’s patent EP 2493466 B1 for a medical use of the ...

30 months in – UPC case load, locations and languages

30 months in – UPC case load, locations and languages

by Matthew Naylor

2025 Week 50 A niche skill of patent attorneys is to be able to think in blocks of 30 months. The UPC opened its doors for business on 1 June 2023 and the 30 month milestone duly rolled around at the ...

Crystal Clear: The Path to Low-Carbon Glass

Crystal Clear: The Path to Low-Carbon Glass

by Rebecca Blundell

Glass is an essential component of modern architecture. Flooding our built spaces with daylight, it improves aesthetics and minimises artificial light sources, whilst shielding us from whatever the ...

UPC first instance decisions on inventive step after Court of Appeal guidance

UPC first instance decisions on inventive step after Court of Appeal guidance

by Matthew Naylor

2025 Week 49 Last week, we reported on the landmark Amgen v. Sanofi / Regeneron and Edwards v. Meril 25 November 2025 decisions from the UPC Court of Appeal (CoA), which together set out the ...

UPC Weekly - Court of Appeal settles the UPC framework for inventive step

UPC Weekly - Court of Appeal settles the UPC framework for inventive step

by Matthew Naylor

2025 Week 48 If you only read one UPC decision this year, read one of these. You can take your pick, based on technical background. Amgen v. Sanofi / Regeneron is in the field of antibodies for ...

Learn More
Forward Magazines Overlapping 8

Mewburn Ellis

FORWARD MAGAZINE

Mewburn Ellis Forward is a biannual publication that celebrates the best of innovation and exploration. Through its pages we hope to inform and entertain, but also to encourage discussion about the most compelling developments taking place in the scientific and entrepreneurial world. Along the way, we’ll engage with the IP challenges that international organisations face every day.